Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gaudium IVF And Women HealthNSE:GAUDIUMIVF +4.99%20 ROE % is 21.95% as of Mar. 2026, which is 58% below its 10-year median of 52.34. GuruFocus rates NSE:GAUDIUMIVF with a GF Score™ of 20/100. The stock has 5 warning signs investors should review. Among 624 Healthcare Providers & Services companies, Gaudium IVF And Women Health ranks better than 74.04% on this metric.
The historical rank and industry rank for Gaudium IVF And Women Health's ROE % or its related term are showing as below:
NSE:GAUDIUMIVF'
s ROE % Range Over the Past 10 Years
Min: 13.97 Med: 52.34 Max: 94.99
Current: 13.97
During the past 5 years, Gaudium IVF And Women Health's highest ROE % was 94.99%. The lowest was 13.97%. And the median was 52.34%.
NSE:GAUDIUMIVF's ROE % is ranked better than 74.04% of 624
companies
in the Healthcare Providers & Services industry
Industry Median: 5.87
vs NSE:GAUDIUMIVF: 13.97
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Gaudium IVF And Women Health ROE % Related Terms
Gaudium IVF And Women Health ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Gaudium IVF And Women Health's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gaudium IVF And Women Health ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Gaudium IVF And Women Health's ROE % distribution charts can be found below:
* The bar in red indicates where Gaudium IVF And Women Health's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) has a ROE % of 21.95% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Gaudium IVF And Women Health and its competitors. This is 58% below median its historical median of 52.34. Over the past decade, Gaudium IVF And Women Health's ROE % has ranged from 13.97 to 94.99. According to the industry distribution chart, Gaudium IVF And Women Health ranks #162 out of 624 companies in the Healthcare Providers & Services industry, placing it in the top 26%.
Is Gaudium IVF And Women Health's ROE % too high?
Gaudium IVF And Women Health's current ROE % of 21.95% is 58% below median its 10-year median of 52.34. Over the past 10 years, this metric has ranged from a low of 13.97 to a high of 94.99. The Healthcare Providers & Services industry median ROE % is 5.87. Gaudium IVF And Women Health's value of 21.95% is 273.9% above this industry median. Based on the distribution chart, Gaudium IVF And Women Health ranks #162 out of 624 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Gaudium IVF And Women Health has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Gaudium IVF And Women Health's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Gaudium IVF And Women Health ranks #162 out of 624 companies for ROE %. This puts Gaudium IVF And Women Health in the upper half of its industry. The industry median ROE % is 5.87. Gaudium IVF And Women Health's value of 21.95% is 273.9% above this benchmark. Historically, Gaudium IVF And Women Health's own ROE % has ranged from 13.97 to 94.99 over the past decade. While the company's 10-year median is 52.34 vs. the industry median of 5.87, Gaudium IVF And Women Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.87, based on 624 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gaudium IVF And Women Health's current ROE % of 21.95% is 273.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Gaudium IVF And Women Health and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gaudium IVF And Women Health's current ROE % is 21.95%, which is 58% below median its own 10-year median of 52.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gaudium IVF And Women Health stock overvalued right now?
Gaudium IVF And Women Health (NSE:GAUDIUMIVF) has a current ROE % of 21.95%. The current ROE % is 21.95%, which is 58% below median its 10-year median of 52.34 and 273.9% above the Healthcare Providers & Services industry median of 5.87. Gaudium IVF And Women Health's overall GF Score™ is 20/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Gaudium IVF And Women Health (NSE:GAUDIUMIVF), the current ROE % is 21.95% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gaudium IVF And Women Health Ltd is engaged in the business of providing healthcare services mainly rendering various fertility treatments such as In Vitro Fertilization (IVF), Intrauterine Insemination (IUI), Intracytoplasmic Sperm Injection (ICSI), Egg Freezing, and laser assisted embryo implantation, amongst others. The company derives the majority of its revenue from business of providing IVF treatment in bundled packages which includes injections, Ovum/Egg Pickup, Embryo Creation and Embryo Transfer.
20GF Score
Get the complete analysis for NSE:GAUDIUMIVF
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:GAUDIUMIVF has been successfully added to your 
